|Position||Trades||Duration||Win rate||Win/loss||Avg win||Avg loss||Return|
|Position||Trades||Duration||Win Rate||Win/Loss||Avg Win||Avg Loss||Return|
ON BALANCE VOLUME
Trading: HOLD @ $2.95
Signal Strength: MEDIUM
Opthea (ASX:OPT) current price has highlighted recent accumulation. Currently, the OBV is 393650.
Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading entry. Indicator can be applied to the short/medium term timeframe, but the best results are obtained with larger cyclical swings in-line with the trend direction. This accumulation / distribution oscillator can provide guidance on the money flow direction from the companies recent trading.
On Balance Volume (OBV) attempts to measure the level of accumulation or distribution by comparing volume to price movements. Volume is added to the indicator if closing price moves up and subtracted if closing price moves down. No adjustment is made if closing price is unchanged.
Calculation: On Balance Volume:
1) If the closing price is above the prior close price then: Current OBV = Previous OBV + Current Volume;
2) If the closing price is below the prior close price then: Current OBV = Previous OBV - Current Volume;
3) If the closing prices equals the prior close price then: Current OBV = Previous OBV (no change)
PROFILE: Opthea (OPT.AX)
Stock Exchange: ASX
Ticker Codes: | OPT.AX | ASX:OPT |
Opthea Limited develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) C and D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead molecule is OPT-302, a soluble form of VEGFR-3, which is in Phase 1/2A clinical trial for the treatment of back of the eye diseases, such as wet age-related macular degeneration that is the cause of blindness in elderly and diabetic populations. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited is based in South Yarra, Australia.
|OCL Objective Corporation||6.49||10||35,078||27,285.5||BULLISH|
|AFL ASX 50||0.18||9.4||520,350||54,318.7||BULLISH|
|MCY Mighty River Power||5||7.1||7,917||3,664.1||BULLISH|
|MEZ Meridian Energy||4.9||4.4||46,590||22,668.5||BULLISH|
|GGG Greenland Minerals||0.13||4||2,348,815||1,009,858.5||BULLISH|
|BPT Beach Petroleum||2.49||3.8||6,575,446||1,931,155.8||BULLISH|
|PNR Pacific Niugini Minerals||0.14||3.7||2,478,287||276,530.6||BULLISH|
|PGC Paragon Care||0.45||3.5||206,495||69,820.1||BULLISH|
|IGL International Goldfields||2.34||3.1||734,472||384,506.9||BULLISH|